Citi Starts BioMarin At Buy With $169 Per Share 'Blue Sky Scenario'
August 30, 2017 at 11:25 AM EDT
Citi analyst Robyn Karnauskas started BioMarin with a Buy rating and $98 price target.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.